Brian Silver
2022
In 2022, Brian Silver earned a total compensation of $1.6M as Chief Financial Officer and Treasurer at TScan Therapeutics, a 50% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $192,000 |
|---|---|
| Option Awards | $910,937 |
| Salary | $480,000 |
| Other | $18,187 |
| Total | $1,601,123 |
Silver received $910.9K in option awards, accounting for 57% of the total pay in 2022.
Silver also received $192K in non-equity incentive plan, $480K in salary and $18.2K in other compensation.
Rankings
In 2022, Brian Silver's compensation ranked 2,118th out of 5,756 executives tracked by ExecPay. In other words, Silver earned more than 63.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,118 out of 5,756 | 63rd |
Division Manufacturing | 1,139 out of 3,133 | 64th |
Major group Chemicals And Allied Products | 488 out of 1,419 | 66th |
Industry group Drugs | 448 out of 1,320 | 66th |
Industry Biological Products, Except Diagnostic Substances | 110 out of 291 | 62nd |
Source: SEC filing on April 25, 2023.
Silver's colleagues
We found two more compensation records of executives who worked with Brian Silver at TScan Therapeutics in 2022.